Raymond L Rosales
Raymond L Rosales is an expert in Neurology at University of Santo Tomas Hospital (Philippines). As of October 2026, ScienceLeadR ranks Raymond L Rosales in the top 1% of experts in the Philippines for Parkinson Disease. Raymond L Rosales has authored 239 publications, the most recent in 2026, and is an investigator in 2 clinical trials. SLR score: 681 (community average: 125). How the SLR is computed.
LeadR Profile
Neurology
Subspecialties: Genetics - Physical Medicine - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1988 - 2026
Number : 239
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Myopathies in clinical care: a focus on treatable causes. PMID 41762439 — muscular diseases, muscles, therapeutics, muscle, skeletal, synaptic transmission | J Neural Transm (Vienna) | 2026 | 0 |
| Unified long-read panel for Parkinson's and repeat expansion disorders. PMID 42786195 — genes | NPJ Parkinsons Dis | 2026 | 0 |
| Add-on safinamide and amantadine in Filipino Parkinson's disease patients with motor fluctuations: a retrospective exploratory cohort study. PMID 42550256 — parkinson disease, cohort studies, dopamine, outcome assessment, health care, therapeutics, amantadine, synaptic transmission | J Neural Transm (Vienna) | 2026 | 0 |
| Managing Antithrombotic Treatment in Intracerebral Hemorrhage and Ischemic Stroke Due to Cerebral Amyloid Angiopathy With Supporting Pathology. PMID 42519249 — diabetes mellitus, cilostazol, cerebral hemorrhage, hemorrhage, ischemic stroke, stroke, pathology, therapeutics, amyloid, cerebral amyloid angiopathy, diabetes mellitus, type 2 | Cureus | 2026 | 0 |
| Iatrogenic botulism: a risk for botulinum toxin's medical use? PMID 41619021 — botulism, tissues, synaptic transmission | J Neural Transm (Vienna) | 2026 | 3 |
Clinical Studies 2
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 6
LeadR Networks
Main global connection map